ÇINAR, G. Et Al. 2018. Tenofovir versus Tenofovir Plus Entecavir in the Treatment of Chronic Hepatitis B in Patients with Poor Efficacy of Nucleoside/ Nucleotide Analogs. 16 th European Meeting on HIV and Hepatitis Treatment Strategies And Antiviral Drug Resistance. , 14.

ÇINAR, G., karadağ, F. Y., KADER, Ç., Korkmaz, F., Tülek, N., SÜER, H. K., ... BATIREL, A.(2018). Tenofovir versus Tenofovir Plus Entecavir in the Treatment of Chronic Hepatitis B in Patients with Poor Efficacy of Nucleoside/ Nucleotide Analogs . 16 th European Meeting on HIV and Hepatitis Treatment Strategies And Antiviral Drug Resistance. (pp.14).

ÇINAR, GÜLE Et Al. "Tenofovir versus Tenofovir Plus Entecavir in the Treatment of Chronic Hepatitis B in Patients with Poor Efficacy of Nucleoside/ Nucleotide Analogs," 16 th European Meeting on HIV and Hepatitis Treatment Strategies And Antiviral Drug Resistance., 2018

ÇINAR, GÜLE Et Al. "Tenofovir versus Tenofovir Plus Entecavir in the Treatment of Chronic Hepatitis B in Patients with Poor Efficacy of Nucleoside/ Nucleotide Analogs." 16 th European Meeting on HIV and Hepatitis Treatment Strategies And Antiviral Drug Resistance. , pp.14, 2018

ÇINAR, G. Et Al. (2018) . "Tenofovir versus Tenofovir Plus Entecavir in the Treatment of Chronic Hepatitis B in Patients with Poor Efficacy of Nucleoside/ Nucleotide Analogs." 16 th European Meeting on HIV and Hepatitis Treatment Strategies And Antiviral Drug Resistance. , p.14.

@conferencepaper{conferencepaper, author={GÜLE ÇINAR Et Al. }, title={Tenofovir versus Tenofovir Plus Entecavir in the Treatment of Chronic Hepatitis B in Patients with Poor Efficacy of Nucleoside/ Nucleotide Analogs}, congress name={16 th European Meeting on HIV and Hepatitis Treatment Strategies And Antiviral Drug Resistance.}, city={}, country={}, year={2018}, pages={14} }